Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Company | Date | Price Target | Rating | Analyst |
|---|---|---|---|---|
| 3/27/2026 | $14.00 | Market Outperform | CJS Securities | |
| 3/27/2026 | $29.00 | Overweight | Stephens | |
| 3/20/2026 | $135.00 | Buy → Hold | DZ Bank | |
| 2/18/2026 | Buy → Hold | Erste Group | ||
| 2/9/2026 | $13.00 | Outperform | Barrington Research | |
| 2/3/2026 | $15.00 | Outperform | Wedbush | |
| 1/21/2026 | $190.00 | Neutral → Buy | Arete | |
| 1/8/2026 | $231.00 → $225.00 | Buy | Jefferies |
CJS Securities initiated coverage of Bioventus with a rating of Market Outperform and set a new price target of $14.00
Stephens resumed coverage of Assoc Banc-Corp with a rating of Overweight and set a new price target of $29.00
DZ Bank downgraded Alibaba from Buy to Hold and set a new price target of $135.00
GREEN BAY, Wis., March 24, 2026 /PRNewswire/ -- Associated Banc-Corp (NYSE:ASB) today announced it expects to release first quarter 2026 financial results on Thursday, April 23, 2026, after market close. The Company also expects to host a conference call for investors and analysts at 4:00 p.m. Central Time (CT) on the same day. Interested parties can access the live webcast of the call through the Investor Relations section of the Company's website, http://investor.associatedbank.com. Parties may also dial into the call at 877-407-8037 (domestic) or 201-689-8037 (international) and request the Associated Banc-Corp first quarter 2026 earnings call. The financial tables and an accompanying sli
TEL AVIV, Israel, March 19, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that its Q1 2026 Aide Memoire is available on the "Investors" page on its website. Q1 2026 Aide Memoire Teva has compiled this document with public information that was previously provided by Teva in order to assist investors ahead of first quarter 2026 results, which are expected to be released on Wednesday, April 29, 2026 at 7am ET, followed by a conference call at 8am ET. The document is based on Teva's prior results, management's previous commentary about Teva's business outlook and data from select independent sources. About Teva Teva Pharmaceutical Indust
TEL AVIV, Israel and PARSIPPANY, N.J., March 19, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will issue a press release on its first quarter 2026 financial results on Wednesday, April 29, 2026, at 7:00 a.m. ET. Following the release, Teva will conduct a conference call and live webcast on the same day, at 8:00 a.m. ET. In order to participate, please register in advance here to obtain a local or toll-free phone number and your personal pin. A live webcast of the call will be available on Teva's website at: https://ir.tevapharm.com/Events-and-Presentations. Following the conclusion of the call, a replay of the webcast will be
4 - Clene Inc. (0001822791) (Issuer)
4 - Clene Inc. (0001822791) (Issuer)
4 - TEVA PHARMACEUTICAL INDUSTRIES LTD (0000818686) (Issuer)
4 - Clene Inc. (0001822791) (Issuer)
6-K - Alibaba Group Holding Ltd (0001577552) (Filer)
6-K - Alibaba Group Holding Ltd (0001577552) (Filer)
8-K - TaskUs, Inc. (0001829864) (Filer)
MILWAUKEE, March 16, 2026 /PRNewswire/ -- Associated Banc-Corp (NYSE:ASB) ("Associated" or "Company") today announced a strategic leadership transition in its Milwaukee market designed to accelerate both local growth and the continued expansion of its national verticals. Effective April 1, Neil Riegelman, senior vice president and head of Commercial Banking – Milwaukee and Madison, will also assume the role of Milwaukee market president. He succeeds John Utz, executive vice president, Milwaukee market president and head of Specialized Industries, who will dedicate his focus to s
First cohort features 7 real-world challenges across R&D, manufacturing and supply chain, commercial and medical affairs Teva's first-ever global innovation platform aims to accelerate patient impact and drive business transformation, as part of its Pivot to Growth StrategyRise will enable startups and tech players worldwide to validate their solutions in real-world settings, scaling impact across Teva's global ecosystem including in the U.S., Europe, Israel and beyond TEL AVIV, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today unveiled Teva Rise, a global open innovation platform designed to harness the power of a variety of disruptive tech
SHANGHAI, Aug. 5, 2025 /PRNewswire/ -- Yum China Holdings, Inc. (the "Company" or "Yum China") (NYSE:YUMC) announced today the appointment of Mr. Zhe (David) Wei to the Board of Directors, effective August 6, 2025. In connection with the appointment, the Board has increased the size of the Board of Directors to 13 directors, 11 of whom are independent. "We warmly welcome David as the newest member of our Board," said Yum China's Chairman Dr. Fred Hu. "David brings deep insights in global and China consumer sectors and significant leadership experience in digital and e-commerce. I am confident that David will be a valuable contributor to our Board." Joey Wat, CEO of Yum China commented, "On
SC 13G/A - Alibaba Group Holding Ltd (0001577552) (Filed by)
SC 13G/A - Clene Inc. (0001822791) (Subject)
SC 13G - Clene Inc. (0001822791) (Subject)
GREEN BAY, Wis., March 24, 2026 /PRNewswire/ -- Associated Banc-Corp (NYSE:ASB) today announced it expects to release first quarter 2026 financial results on Thursday, April 23, 2026, after market close. The Company also expects to host a conference call for investors and analysts at 4:00 p.m. Central Time (CT) on the same day. Interested parties can access the live webcast of the call through the Investor Relations section of the Company's website, http://investor.associatedbank.com. Parties may also dial into the call at 877-407-8037 (domestic) or 201-689-8037 (international) and request the Associated Banc-Corp first quarter 2026 earnings call. The financial tables and an accompanying sli
TEL AVIV, Israel, March 19, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that its Q1 2026 Aide Memoire is available on the "Investors" page on its website. Q1 2026 Aide Memoire Teva has compiled this document with public information that was previously provided by Teva in order to assist investors ahead of first quarter 2026 results, which are expected to be released on Wednesday, April 29, 2026 at 7am ET, followed by a conference call at 8am ET. The document is based on Teva's prior results, management's previous commentary about Teva's business outlook and data from select independent sources. About Teva Teva Pharmaceutical Indust
TEL AVIV, Israel and PARSIPPANY, N.J., March 19, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will issue a press release on its first quarter 2026 financial results on Wednesday, April 29, 2026, at 7:00 a.m. ET. Following the release, Teva will conduct a conference call and live webcast on the same day, at 8:00 a.m. ET. In order to participate, please register in advance here to obtain a local or toll-free phone number and your personal pin. A live webcast of the call will be available on Teva's website at: https://ir.tevapharm.com/Events-and-Presentations. Following the conclusion of the call, a replay of the webcast will be